Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
Zhonghua Nei Ke Za Zhi ; 59(7): 528-534, 2020 Jul 01.
Article in Chinese | MEDLINE | ID: mdl-32594686

ABSTRACT

Objective: To investigate the significance of plasma pentraxin 3 (PTX3) in patients with secondary hemophagocytic lymphohistiocytosis (sHLH). Methods: Plasma PTX3 levels were tested by ELISA in 48 newly diagnosed sHLH patients, 18 healthy volunteers and 9 lymphoma controls in the First Affiliated Hospital of Nanjing Medical University from January 2017 to July 2019. Clinical parameters were collected, and the correlations with PTX3 levels were analyzed. Results: PTX3 level in newly diagnosed group was significantly higher than that of healthy control group [16.29(1.17-66.00) vs. 0.76(0.01-7.86) µg/L, P<0.01]. Patients with lymphoma-associated HLH(LHLH) had higher plasma level of PTX3 than Fhose with infection-associated HLH (IHLH) [24.29(3.36-66.00) vs. 9.56(1.17-36.50)µg/L, P<0.05]. Plasma PTX3 levels in 48 sHLH patients were positively correlated with serum ferritin (P<0.05). Receiver operating characteristic (ROC) curve for plasma PTX3 levels of sHLH and healthy controls produced a cutoff value at 3.9 µg/L, with its 86.7% sensitivity and 94.4% specificity. And ROC analysis showed that PTX3 17.5 µg/L was the critical value for diagnosis of LHLH from non-LHLH group, that the sensitivity and specificity were 63.0% and 76.2% respectively. The 1-year overall survival (OS) rate in patients with PTX3≥17.5 µg/L was significantly lower in those with PTX3<17.5 µg/L (18.5% vs. 75.8%, P<0.01). Conclusion: These results indicate the potential of PTX3 as a biomarker for diagnosis and prognosis in patients with sHLH.


Subject(s)
C-Reactive Protein , Lymphohistiocytosis, Hemophagocytic , Serum Amyloid P-Component , Biomarkers, Tumor , C-Reactive Protein/analysis , Humans , Lymphohistiocytosis, Hemophagocytic/diagnosis , ROC Curve , Sensitivity and Specificity , Serum Amyloid P-Component/analysis
2.
J Endocrinol Invest ; 43(4): 529-538, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31741320

ABSTRACT

PURPOSE: Achieving biochemical control (normalization of insulin-like growth factor-1 [IGF-1] and growth hormone [GH]) is a key goal in acromegaly management. However, IGF-1 and GH fluctuate over time. The true potential impact of time-varying biochemical control status on comorbidities is unclear and relies on multiple, longitudinal IGF-1 and GH measurements. This study assessed the association between time-varying biochemical control status and onset of selected comorbidities in patients with acromegaly. METHODS: Medical charts of adults with confirmed acromegaly and ≥ 6 months of follow-up at an Italian endocrinology center were reviewed. Patients were followed from the first diagnosis of acromegaly at the center until loss to follow-up, chart abstraction, or death. Biochemical control status was assessed annually and defined as IGF-1 ≤ the upper limit of normal, or GH ≤ 2.5 µg/L in the few cases where IGF-1 was unavailable. Time-varying Cox models were used to assess the association between biochemical control status and comorbidities. RESULTS: Among 150 patients, 47% were female, average age at diagnosis was 43.1, and mean length of follow-up was 10.4 years. Biochemical control was significantly associated with a lower hazard of diabetes (HR = 0.36, 95% CI 0.15; 0.83) and cardiovascular system disorders (HR = 0.54, 95% CI 0.31; 0.93), and a higher hazard of certain types of arthropathy (HR = 1.68, 95% CI 1.04; 2.71); associations for other comorbidities did not reach statistical significance. CONCLUSION: Results further support the importance of achieving biochemical control, as this may reduce the risk of high-burden conditions, including diabetes and cardiovascular system disorders. The association for arthropathy suggests irreversibility of this impairment. Due to limitations, caution is required when interpreting these results.


Subject(s)
Acromegaly/blood , Cardiovascular Diseases/complications , Human Growth Hormone/blood , Insulin-Like Growth Factor I/metabolism , Acromegaly/complications , Adult , Female , Humans , Italy , Longitudinal Studies , Male , Middle Aged , Retrospective Studies
3.
Zhonghua Xue Ye Xue Za Zhi ; 40(6): 502-506, 2019 Jun 14.
Article in Chinese | MEDLINE | ID: mdl-31340624

ABSTRACT

Objective: To investigate the clinical characteristics of secondary hemophagocytic lymphohistiocytosis (sHLH) complicated with capillary leak syndrome (CLS) . Methods: The clinical and laboratory data of 87 sHLH patients, who were treated in our hospital between January 2015 and December 2017, were retrospectively analyzed. Depending on whether they were complicated with CLS, 21 sHLH patients were classified as the CLS-sHLH group, while 66 were classified as the non-CLS-sHLH group. The differences of clinical manifestations, laboratory tests, treatment and prognosis between the two groups were compared. Results: There was no significant difference in the etiology of sHLH between the CLS-sHLH group and the non-CLS-sHLH group (P>0.05) . The neutrophil, fibrinogen and albumin levels in the CLS-sHLH group were lower than those in the non-CLS-sHLH group, while the triacylglycerol levels were higher than those in the non-CLS-sHLH group (P<0.05) . Varying degrees of edema, weight gain, hypotension, hypoproteinemia, oliguria and multiple serous effusions were observed in the CLS-sHLH group. Among them, there were 15 patients that CLS get improved, and the medial time of improvement was 7 (5-14) days. The other 6 patients did not get remission, while they died within 6-30 days. The median overall survival of the CLS-sHLH group was lower than that of the non-CLS-sHLH group (75 days vs not reached, P=0.031) . Conclusions: There may be no correlation between the cause of sHLH and the occurrence of CLS. Severity of neutropenia, fibrinogen and albumin levels, and triglyceride levels may be accompanied for sHLH patients complicated with CLS. Patients with sHLH who complicated with CLS have a poor prognosis. Active treatment of HLH and its primary disease, reasonable fluid replacement and oxygen supply are crucial, which can effectively control disease progression.


Subject(s)
Capillary Leak Syndrome , Lymphohistiocytosis, Hemophagocytic , Fibrinogen , Humans , Prognosis , Retrospective Studies
4.
Prev Med Rep ; 14: 100833, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30886816

ABSTRACT

Hepatitis A and B vaccine coverage is suboptimal in US adults, even among those at increased risk for infection, morbidity, or mortality. To understand where medical education and resources might enhance vaccine coverage, it is important to first identify providers and places most commonly associated with the administration of hepatitis vaccinations. We conducted a retrospective analysis of commercial and Medicare insurance claims data from 2007 to 2015 to describe provider types and places of vaccination against hepatitis A and B among adults in the US, and estimated the time to initial vaccination from first diagnosis of a condition for which the Advisory Committee on Immunization Practices (ACIP) recommends hepatitis A and/or B vaccination among at-risk adults. We identified 183,326 adults who received hepatitis A vaccine, 148,119 hepatitis B vaccine, and 64,953 a bivalent vaccine. Mean age was 42.1-45.8 years. Family practice and internal medicine physicians were the main vaccine providers: 38.9% and 20.2% for hepatitis A, 43.7% and 21.4% for hepatitis B, 35.3% and 15.9% for bivalent vaccinations, respectively. ≥90% of initial vaccinations occurred in an office practice. In at-risk patients, median time to first-dose received was 11.8, 20.9, and 20.9 months for hepatitis A, hepatitis B, and hepatitis A/B vaccines, respectively. Primary care and office practices were the most common providers and places of vaccination, respectively, for hepatitis A and B vaccine. For at-risk patients, further research is needed to design vaccination strategies to improve the median time from first ACIP-recommended condition diagnosis to initial vaccination against hepatitis A and B.

8.
Eur J Clin Nutr ; 69(3): 322-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25248358

ABSTRACT

BACKGROUND/OBJECTIVES: The prevalence of metabolic syndrome (MetS) and obesity has increased worldwide, as well as in Taiwan, particularly in women aged>40 years. The purpose of this study was to elucidate the effects of a calorie-restriction diet (CR) supplemented with protein and n-3 polyunsaturated fatty acids (PUFAs) on women with MetS. SUBJECTS/METHODS: A total of 143 eligible female participants were recruited and assigned to four dietary interventions such as 1500-kcal CR, calorie-restriction meal-replacement diet (CRMR), calorie-restriction diet with fish oil supplementation (CRF) and calorie-restriction meal-replacement diet with fish oil supplementation (CRMRF). The changes in anthropometric measures, metabolic profiles, inflammatory response and the Z-score of severity of MetS were evaluated. RESULTS: Among 143 female MetS patients enrolled, 136 patients completed the 12-week study. After the 12-week dietary interventions, we observed reductions in body weight (BW), body mass index (BMI) and waist circumference (WC) in all groups. BMI and triglyceride (TG) levels decreased significantly in the CRMR, CRF and CRMRF groups, but not in the CR group. The homeostasis model assessment of insulin resistance (HOMA-IR) had significantly improved in all four groups, and the levels of interleukin-6 (IL-6) and C-reactive protein (CRP) had significantly decreased in the CRF and CRMRF groups. Following the interventions, the changes in waist circumference (WC), mean arterial pressure (MAP), fasting blood glucose (FBG), TGs, HOMA-IR, CRP and IL-6 significantly correlated with the reductions in Z-score of MetS severity. CONCLUSIONS: Our study results indicate that a calorie-restriction dietary intervention combined with various macronutrients can reduce the severity of MetS in women and increase recovery from MetS by almost twofold in comparison with a CR alone.


Subject(s)
Caloric Restriction , Dietary Proteins/therapeutic use , Dietary Supplements , Fish Oils/therapeutic use , Metabolic Syndrome/diet therapy , Obesity/complications , Adult , Body Mass Index , C-Reactive Protein/metabolism , Dietary Proteins/administration & dosage , Dietary Proteins/pharmacology , Female , Fish Oils/pharmacology , Humans , Insulin Resistance , Interleukin-6/blood , Metabolic Syndrome/blood , Severity of Illness Index , Waist Circumference
9.
J Helminthol ; 89(1): 124-9, 2015 Jan.
Article in English | MEDLINE | ID: mdl-23890204

ABSTRACT

The genetic variations in internal transcribed spacers (ITS) spanning ITS-1, 5.8S and ITS-2 rDNA of Dicrocoelium dendriticum, isolated from sheep and goats in four geographical regions in Shaanxi province, were examined. The lengths of ITS-1, 5.8S and ITS-2 rDNA sequences for D. dendriticum were 749 bp, 161 bp and 234 bp, respectively. Intra-specific sequence variations of D. dendriticum were 0-0.5% for ITS-1 and 0-1.3% for ITS-2 rDNA, while the inter-specific variations among species in genus Dicrocoelium in ITS-2 rDNA were 3.4-12.3%. Phylogenetic analysis based on sequences of ITS-2 rDNA showed that all D. dendriticum isolates in the present study were grouped with reference D. dendriticum isolates from sheep and goats, and D. dendriticum isolates from cattle and Japanese serow were clustered in a sister clade. However, the phylogenetic tree could not reveal geographically genetic relationships of D. dendriticum isolates in different origins and hosts. These findings provided basic information for further study of molecular epidemiology and control of D. dendriticum infection in Shaanxi province as well as in the world.


Subject(s)
Dicrocoeliasis/veterinary , Dicrocoelium/isolation & purification , Ruminants/parasitology , Animals , Base Sequence , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/parasitology , China/epidemiology , DNA, Helminth/genetics , DNA, Ribosomal Spacer/genetics , Deer , Dicrocoeliasis/epidemiology , Dicrocoeliasis/parasitology , Dicrocoelium/classification , Dicrocoelium/genetics , Goat Diseases/epidemiology , Goat Diseases/parasitology , Goats , Molecular Sequence Data , Phylogeny , Ruminants/classification , Sheep , Sheep Diseases/epidemiology , Sheep Diseases/parasitology
10.
J Helminthol ; 89(3): 259-66, 2015 May.
Article in English | MEDLINE | ID: mdl-24331581

ABSTRACT

Internal transcribed spacer (ITS) rDNA sequences of three Nematodirus species from naturally infected goats or sheep in two endemic provinces of China were analysed to establish an effective molecular approach to differentiate Nematodirus species in small ruminants. The respective intra-specific genetic variations in ITS1 and ITS2 rDNA regions were 0.3-1.8% and 0-0.4% in N. spathiger, 0-6.5% and 0-5.4% in N. helvetianus, and 0-4.4% and 0-6.1% in N. oiratianus from China. The respective intra-specific variations of ITS1 and ITS2 were 1.8-4.4% and 1.6-6.1% between N. oiratianus isolates from China and Iran, 5.7-7.1% and 6.3-8.3% between N. helvetianus samples from China and America. For N. spathiger, compared with samples from China, sequence differences in ITS1 rDNA were 0.3-2.4% in isolates from America, 0.3-2.9% in New Zealand and 2.1-2.4% in Australia. Genetic variations in ITS2 rDNA of N. spathiger were 0-0.4% between samples from China and America, and 0-0.8% between samples from China and New Zealand. Using mutation sites, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and specific PCR techniques were developed to differentiate these three Nematodirus species. The specific PCR assay allowed the accurate identification of N. oiratianus from other common nematodes with a sensitivity of 0.69 pg and further examination of Nematodirus samples demonstrated the reliability of these two molecular methods.


Subject(s)
Genetic Variation , Goat Diseases/parasitology , Molecular Diagnostic Techniques/methods , Nematodirus/classification , Nematodirus/genetics , Sheep Diseases/parasitology , Strongylida Infections/veterinary , Animals , China , Cluster Analysis , DNA Primers/genetics , DNA, Helminth/chemistry , DNA, Helminth/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Goats , Molecular Sequence Data , Nematodirus/isolation & purification , Phylogeny , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Sensitivity and Specificity , Sequence Analysis, DNA , Sheep , Strongylida Infections/parasitology
11.
Br J Pharmacol ; 157(5): 746-56, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19422389

ABSTRACT

BACKGROUND AND PURPOSE: The transcription factor nuclear factor-kappaB (NF-kappaB) has been linked to the cell growth, apoptosis and cell cycle progression. NF-kappaB blockade induces apoptosis of cancer cells. Therefore, NF-kappaB is suggested as a potential therapeutic target for cancer. Here, we have evaluated the anti-cancer potential of a novel NF-kappaB inhibitor, quinoclamine (2-amino-3-chloro-1,4-naphthoquinone). EXPERIMENTAL APPROACH: In a large-scale screening test, we found that quinoclamine was a novel NF-kappaB inhibitor. The global transcriptional profiling of quinoclamine in HepG2 cells was therefore analysed by transcriptomic tools in this study. KEY RESULTS: Quinoclamine suppressed endogenous NF-kappaB activity in HepG2 cells through the inhibition of IkappaB-alpha phosphorylation and p65 translocation. Quinoclamine also inhibited induced NF-kappaB activities in lung and breast cancer cell lines. Quinoclamine-regulated genes interacted with NF-kappaB or its downstream genes by network analysis. Quinoclamine affected the expression levels of genes involved in cell cycle or apoptosis, suggesting that quinoclamine exhibited anti-cancer potential. Furthermore, quinoclamine down-regulated the expressions of UDP glucuronosyltransferase genes involved in phase II drug metabolism, suggesting that quinoclamine might interfere with drug metabolism by slowing down the excretion of drugs. CONCLUSION AND IMPLICATIONS: This study provides a comprehensive evaluation of quinoclamine by transcriptomic analysis. Our findings suggest that quinoclamine is a novel NF-kappaB inhibitor with anti-cancer potential.


Subject(s)
Antineoplastic Agents/pharmacology , Gene Expression Profiling , NF-kappa B/antagonists & inhibitors , Naphthoquinones/pharmacology , Apoptosis/drug effects , Apoptosis/genetics , Cell Cycle/drug effects , Cell Cycle/genetics , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Gene Expression Profiling/methods , Gene Expression Regulation/drug effects , Gene Regulatory Networks , Glucuronosyltransferase/genetics , Humans , I-kappa B Proteins/metabolism , NF-KappaB Inhibitor alpha , NF-kappa B/genetics , NF-kappa B/metabolism , Oligonucleotide Array Sequence Analysis , Phosphorylation , Protein Transport , Transcription Factor RelA/metabolism , Transfection
12.
J Appl Microbiol ; 102(6): 1636-44, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17578429

ABSTRACT

AIMS: To characterize the efficacy of widely accepted heat and chlorination on culturable and non-culturable Legionella pneumophila in starved and warm water. METHODS AND RESULTS: For L. pneumophila starved for 1 day (S1), heating at 60 degrees C or more for 30 min or chlorination at 0.5-20 mg l(-1) for 60 min, a loss of 6-8 log culturability was observed, whereas only 17-47% of cells had membrane damage. Non-culturability was also observed after heating or chlorinating the cells starved for 14 days (S14). The effect of heating on membrane deterioration was reduced for S14 cells while the chlorination effect remained. Legionella pneumophila entered a non-culturable phase after being starved for 33-40 days. The disinfection effects of both heating and chlorination on non-culturable N4 and N35 cells (which were collected on the fourth and the 35th days of the non-culturability phase respectively) decreased, indicating the development of disinfection resistance among non-culturable cells that had been subjected to starvation for 1-2 months. CONCLUSIONS: Heating and chlorination significantly reduce the culturability of starved L. pneumophila, and damage cell membrane to a much less extent. SIGNIFICANCE AND IMPACT OF THE STUDY: This study shows the ability of long-term starved L. pneumophila to resist against disinfection treatments, which has implications in terms of public health.


Subject(s)
Disinfection/methods , Halogenation/physiology , Hot Temperature , Legionella pneumophila/physiology , Water Microbiology , Cell Membrane/physiology , Colony Count, Microbial , Culture Media
13.
Anaesth Intensive Care ; 35(1): 68-73, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17323669

ABSTRACT

Recall and information sources regarding the risks of regional anaesthesia in women having lower segment caesarean section have not been adequately assessed previously. We aimed to survey women's recall of their pre-anaesthesia risk discussion and determine where women, presenting for lower segment caesarean section under regional anaesthesia, obtain risk information. Following a small pilot survey, women's responses were recorded for "spontaneous" or "prompted" recalled risks, the information source and its reliability. One-hundred and fifty women were surveyed following caesarean section. Seventy women (46.7%) had an elective procedure and 80 (53.3%) had an emergency procedure. Overall, 142 women (94.6%) recalled at least four risks (44.6% spontaneously; 66% prompted). Of those women giving at least four spontaneous responses, 41 (58.6%) had elective and 26 (32.5%) had emergency lower segment caesarean section (P = 0.001). The majority of women stated that anaesthetists were the main, and most reliable, source of their information regarding risks of regional anaesthesia for caesarean section. This report identifies the risks associated with regional anaesthesia for caesarean section that women most frequently recall, namely headache, paralysis, nerve damage and inadequate block.


Subject(s)
Anesthesia, Conduction/adverse effects , Anesthesia, Obstetrical/adverse effects , Cesarean Section , Mental Recall , Patient Education as Topic , Surveys and Questionnaires , Adolescent , Adult , Australia , Chi-Square Distribution , Female , Follow-Up Studies , Humans , Middle Aged , Pregnancy , Risk Factors
14.
Int J Cardiol ; 119(2): 277-9, 2007 Jul 10.
Article in English | MEDLINE | ID: mdl-17126427

ABSTRACT

Particulate and histopathologic examination of atherosclerotic material collected during carotid artery stenting is presented, illustrating the limitations of current knowledge regarding the use of distal protection devices (DPD) during this novel vascular intervention.


Subject(s)
Arteriosclerosis/pathology , Coronary Stenosis/pathology , Coronary Stenosis/therapy , Stents , Filtration/instrumentation , Humans , Intracranial Embolism/etiology , Intracranial Embolism/prevention & control , Male , Middle Aged , Particle Size
15.
Minim Invasive Neurosurg ; 49(5): 257-62, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17163337

ABSTRACT

The supraorbital keyhole approach is most frequently used in treatment for lesions within the anterior cranial base. However, it has some drawbacks, including cosmetically poor appearance of the scar, forehead deformity, and difficulty in dealing with some kinds of middle cerebral artery (MCA) and internal carotid artery (ICA) aneurysms. Therefore, we have developed a small pterion keyhole approach for an alternative access to treat anterior circulation aneurysms. An oblique skin incision about 3-5 cm in length was made just from 1.0 cm anterior to the superficial temporal artery at the level of the zygomatic arch, curved just below the temporal line to the forehead, and stopped at the hairline over the sylvian fissure. Then a small craniotomy (2-3 cm) was made just over the sylvian fissure and the aneurysms were exposed through the lateral cerebral fissure. We used this approach to treat 40 patients with aneurysms located in posterior communicating arteries (n=14), the MCA (n=10), the anterior communicating arteries (n=9), the anterior cerebral artery (n=1), the ophthalmic arteries (n=3), and the ICA (n=3). The general outcome of all patients was good without serious complications from the surgical technique even though 3 cases underwent intraoperative premature rupture of the aneurysms. No approach-related complication occurred except that one patient had vasospasm 2 days after the aneurysm clipping. In conclusion, this pterion keyhole approach can achieve the best operative effect for the treatment of intracranial anterior circulation aneurysms in a selective group of patients with several advantages over traditional craniotomy including minor tissue damage, less brain retraction, a superior cosmetic result, and shorter duration of surgery. Moreover, the operative field becomes wider in the deep area, providing sufficient space for microscope-assisted surgery without the need for highly specialized instruments.


Subject(s)
Craniotomy/methods , Intracranial Aneurysm/surgery , Minimally Invasive Surgical Procedures/methods , Neurosurgical Procedures/methods , Adult , Aged , Aged, 80 and over , Anterior Cerebral Artery/surgery , Cicatrix/prevention & control , Congenital Abnormalities/prevention & control , Craniotomy/adverse effects , Female , Humans , Male , Microsurgery/methods , Middle Aged , Minimally Invasive Surgical Procedures/adverse effects , Neurosurgical Procedures/adverse effects , Treatment Outcome
16.
Minim Invasive Neurosurg ; 49(5): 305-8, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17163346

ABSTRACT

PURPOSE: This report presents our experience in using a minimally invasive keyhole approach to remove a migratory balloon in the cerebral artery in one patient. CASE REPORT: A 19-year-old male suffered from carotid-cavernous fistula after craniofacial trauma two months previously. The patient received endovascular embolization of a carotid-cavernous fistula with detachable balloons. Unfortunately, migration of one balloon to the right middle cerebral artery (MCA) at the M1-M2 junction was noted after detaching the balloon during this procedure. Volume expansion, anticoagulation therapy and an emergency pterional keyhole approach with removal of the displaced balloon were performed successfully. Transient left hemiparesis due to temporary occlusion of the right middle cerebral artery by the balloon was promptly alleviated. There was no definite neurological sequel after the operation. CONCLUSIONS: Although detachable balloon embolization is the best initial treatment of direct carotid-cavernous fistulas, it is likely to migrate to downstream cerebral arteries. We recommend a minimally invasive pterional keyhole approach as a good alternative for treating such endovascular complications to improve outcome.


Subject(s)
Balloon Occlusion/adverse effects , Carotid-Cavernous Sinus Fistula/therapy , Minimally Invasive Surgical Procedures/methods , Neurosurgical Procedures/methods , Prosthesis Failure , Adult , Carotid-Cavernous Sinus Fistula/pathology , Cerebral Angiography , Cerebral Arteries/pathology , Cerebral Arteries/surgery , Humans , Male , Tomography, X-Ray Computed , Treatment Outcome
17.
Minim Invasive Neurosurg ; 47(3): 181-5, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15343437

ABSTRACT

Primary brain tumors associated with intracranial aneurysm are rare. A combination of glioblastoma multiforme (GBM) with cerebral aneurysm is even more rare. We present a 67-year-old female, who suffered from progressive weakness of the right limbs and dysphasia for 2 days. She was referred from another hospital with impression of having a brain tumor. The non-enhanced computed tomographic (CT) scan of the brain showed a mass lesion over the left parietal region, and another tiny lesion with relatively high density over the left suprasellar region. After admission, the carotid angiogram revealed a 13 x 12 x 14 mm aneurysm with a base about 8 mm from the anterior wall of the left supraclinoid internal carotid artery (ICA) between the left ophthalmic artery and the left anterior choroid artery. We first clipped the aneurysm by a basal pterion keyhole approach. One week later, the tumor was en bloc removed by a small left parietal craniotomy under the guidance of a navigator. The final diagnosis was confirmed by histopathological examination as GBM. After the surgeries, the patient received palliative radiotherapy with a dose of 4000 cGy. She recovered well with no evidence of recurrence of the tumor one year after the operations. In this report, the careful diagnosis and the possible mechanisms of concurring GBM and cerebral aneurysm, as well as the strategies of surgical treatment involving minimally invasive approaches are discussed.


Subject(s)
Brain Neoplasms/complications , Brain Neoplasms/surgery , Glioblastoma/complications , Glioblastoma/surgery , Intracranial Aneurysm/etiology , Intracranial Aneurysm/surgery , Minimally Invasive Surgical Procedures/methods , Neuronavigation , Neurosurgical Procedures/methods , Aged , Brain Neoplasms/radiotherapy , Female , Glioblastoma/radiotherapy , Humans , Surgical Instruments , Treatment Outcome
18.
Anaesth Intensive Care ; 32(4): 542-7, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15675215

ABSTRACT

This prospective study was designed to elucidate barriers limiting effective perioperative communication between indigenous Australians and anaesthetists, and to identify strategies for improving communication. A questionnaire was used to collect data on 1040 consecutive patients undergoing anaesthesia at Royal Darwin Hospital between February and March 2003. 27.1% of these patients described themselves as Aboriginal. Aboriginal patients were more likely to undergo emergency surgery and were more likely to be classified as ASA 3, 4 or 5 than non-indigenous patients. Communication difficulties were identified in 28.7% of all Aboriginal patients, which was 31 times higher than those in non-Aboriginal patients. The most common reason identified for this was difficulty in speaking English. Only 17.7% of Aboriginal patients presenting to the operating theatre spoke English as their first language. Unfortunately, the anaesthetic team utilized the Aboriginal interpreter service in only a minority of cases. Communication difficulty in indigenous Australians is pervasive and often goes unrecognized. The results suggest that heath care providers may need staff training in cross-cultural communication and that protocols need to be developed within the health care system so that interpreters are called upon automatically early in the admission process.


Subject(s)
Anesthesiology , Communication Barriers , Native Hawaiian or Other Pacific Islander , Physician-Patient Relations , Preoperative Care , Adolescent , Adult , Child , Child, Preschool , Emergency Medical Services , Humans , Infant , Interviews as Topic , Middle Aged , Northern Territory , Surveys and Questionnaires , Translating
19.
Pediatr Neurosurg ; 34(5): 247-51, 2001 May.
Article in English | MEDLINE | ID: mdl-11423776

ABSTRACT

Being the most common childhood tumor to involve the hypothalamus and pituitary gland, craniopharyngioma, a histologically benign tumor, is usually related to growth retardation and hypogonadism. The presentation of precocious puberty is very rare for a hypothalamic craniopharyngioma. Here, we report such a case. The female patient had presented with symptoms of menarche and breast development since she was 6 years old. Hormonal therapy with a gonadotropin-releasing hormone analogue was instituted to cease precocious puberty but was unsuccessful. Magnetic resonance imaging of the sella showed a 1-cm tumor in the hypothalamic area. Through a pterional approach, the tumor was removed en bloc with endoscope-assisted microsurgery. After the operation, our patient's symptoms improved, so the hormone therapy was discontinued. This extremely unique association of craniopharyngioma and precocious puberty, the causes and mechanisms involved along with the advantages of endoscope-assisted microsurgery are discussed.


Subject(s)
Craniopharyngioma/complications , Craniopharyngioma/surgery , Endoscopy , Pituitary Neoplasms/complications , Pituitary Neoplasms/surgery , Puberty, Precocious/etiology , Child , Craniopharyngioma/pathology , Female , Humans , Microsurgery/methods , Pituitary Neoplasms/pathology
20.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 23(4): 365-8, 2001 Aug.
Article in Chinese | MEDLINE | ID: mdl-12940078

ABSTRACT

OBJECTIVE: To evaluate positron emission tomography (PET) in diagnosing and staging of lung cancer. METHODS: One hundred and forty-seven patients (93 with lung cancer, 15 with lung metastatic tumors, 39 with benign lesions) were involved in the study. 163 whole body examinations (twice in 12 cases and 3 times in 2 cases) were performed after injection of 18F-fluro-deoxy-glucose (18FDG) with a Siemens ECAT EXACT HR + PET system. The results of PET were compared with pathological diagnoses (112 cases), clinical follow-up (35 cases), CT (68 malignant and 30 benign cases), and other imaging diagnoses. RESULTS: For the 147 cases with lung lesions, the sensitivity, specificity, and accuracy of FDG PET in differentiating the malignant from the benign were 97.2%, 89.7%, and 94.6% respectively. For the 93 lung cancer cases, more lesions were detected by PET in 58 (62.4%) cases, and changed staging in 36 (38.7%). In the 98 cases examinations, PET positive findings were consistent with CT in 39 (39.8%) cases; PET detected more lesions than CT in 29 (29.6%) cases; the lesions detected by CT were negative or with low uptake in the PET images in 30 (30.6%) cases, and they were finally proved as benign by follow-up. However, CT provided better detailed anatomical structures of the lesions than PET, and image fusion should give more information about the lesions. CONCLUSIONS: FDG PET had advantages in diagnosing and staging of lung cancer by providing metabolic information of the lesions. Comparison and fusion of PET with CT will give much help to clinical diagnosis.


Subject(s)
Lung Neoplasms/diagnostic imaging , Tomography, Emission-Computed , Fluorodeoxyglucose F18 , Humans , Lung Neoplasms/pathology , Neoplasm Staging , Radiopharmaceuticals , Sensitivity and Specificity , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...